http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004037773-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a85bfd382c31562285cdcf097098820 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2003-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_574a7a997c0e05ca545bf77668abbfd6 |
| publicationDate | 2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004037773-A1 |
| titleOfInvention | Method for detecting abnormal tissue using enhanced radiopharmaceutical uptake |
| abstract | The invention provides a method for detecting abnormal tissue by enhancing the vascularity of abnormal tissue using a vasodilatory agent prior to administering a radiopharmaceutical which selectively accumulates in abnormal tissue. In one embodiment the vasodilatory agent is dipyridamole and the radiopharmaceutical is is Technetium-99m hexakis 2-methoxyisobutylisonitrile (sestamibi). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015064109-A1 |
| priorityDate | 2002-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.